Bonus Material-02_Ryu_Mediastinal and Other Neoplasms 2025

Pdf Summary

This comprehensive lecture by Dr. Jay H. Ryu covers uncommon intrathoracic tumors, especially mediastinal masses and other neoplasms, relevant to pulmonary disease certification. The presentation aims to familiarize clinicians with diagnostic approaches, clinical presentations, management, and prognosis of rare thoracic tumors.<br /><br />Uncommon lung neoplasms include neuroendocrine tumors (NETs such as typical and atypical carcinoids), salivary gland-type carcinomas (mucoepidermoid and adenoid cystic carcinoma), hamartomas, pulmonary MALT lymphoma, plasmacytomas, sarcomas, and metastatic tumors. Lung NETs account for 2% of thoracic tumors, typically occurring in middle-aged adults without smoking association. Low-grade typical carcinoids have indolent courses with surgery as curative; intermediate-grade atypical carcinoids are more aggressive. Hamartomas are the most common benign lung tumors, often found incidentally, showing fat and calcifications on imaging. Salivary gland-type carcinomas arise in bronchial glands, treated by resection with generally good prognosis. Pulmonary MALT lymphoma is a low-grade B-cell lymphoma associated with autoimmune disease; management ranges from observation to rituximab or radiation. Plasmacytomas can present as solitary lesions with risk of progression to multiple myeloma. Sarcomas rarely originate primarily in the lung and often represent metastatic disease.<br /><br />Mediastinal tumors are anatomically classified into anterior, middle, and posterior compartments. The anterior mediastinum commonly harbors thymomas (20% of mediastinal tumors), lymphomas, germ cell tumors, and thyroid masses. Thymomas may be associated with paraneoplastic syndromes like myasthenia gravis; primary treatment is surgical resection. Mediastinal lymphomas typically affect young adults and present with systemic B symptoms, managed with chemotherapy and radiation. Germ cell tumors often affect young men and include teratomas (mostly benign), seminomas, and non-seminomatous tumors, with treatment tailored accordingly. Intrathoracic thyroid masses usually represent goiters extending into the mediastinum.<br /><br />Middle mediastinal masses often represent lymphadenopathy due to malignancy or infections, and benign cysts like bronchogenic or pericardial cysts. Posterior mediastinal tumors are predominantly neurogenic, including benign schwannomas and neurofibromas, occasionally malignant, often requiring surgical excision.<br /><br />Other mediastinal masses include vascular lesions, mediastinal lipomatosis, lymphangiomas, and rare entities like paragangliomas. Imaging with contrast-enhanced CT is the frontline diagnostic tool, with MRI and PET/CT used selectively. Biopsy decisions depend on the tumor type, resectability, and clinical context. Management ranges from observation for asymptomatic benign lesions to multimodal treatments for malignancies.<br /><br />This lecture highlights the importance of integrating clinical presentation, imaging characteristics, and histopathology to achieve accurate diagnosis and optimal management of rare intrathoracic tumors and mediastinal masses.

Meta Tag

Concept Thoracic Tumor

Concept Mediastinal Mass

Concept Biopsy

Concept Thymoma

Concept Diagnostic Imaging

Keywords

intrathoracic tumors

mediastinal masses

pulmonary neoplasms

neuroendocrine tumors

thymoma

carcinoid tumor

hamartoma

pulmonary MALT lymphoma

germ cell tumor

posterior mediastinal tumors

Thoracic Tumor

Mediastinal Mass

Biopsy

Thymoma

Diagnostic Imaging